Plain-English translation of NCT06952153 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two surgical approaches for people with primary angle-closure glaucoma, a serious eye condition where fluid pressure builds up in the eye. One approach combines cataract removal with a procedure to open the drainage angle in your eye (phacoemulsification with goniosynechialysis). The other is a traditional filtration surgery called trabeculectomy, which creates a new drainage pathway. The study will compare how well each surgery controls eye pressure and which one has fewer complications over 12 months.
Angle-closure glaucoma can cause vision loss if not treated, and doctors need better information about which surgery works best. This trial exists to help doctors understand whether combining cataract removal with angle opening is as effective as traditional filtering surgery, especially for patients who already need cataract surgery.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive one of two surgeries: either cataract removal combined with angle-opening surgery, or traditional filtration surgery. Both surgeries will be performed by experienced glaucoma specialists, and you will follow the same postoperative care plan. You will have follow-up visits over at least 12 months to check your eye pressure, vision, and overall eye health, and the doctors will monitor you for any side effects.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Vietnam